1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
43 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD) and biotech diagnostics, which refers to testing samples of blood, tissue, for example electrocardiography or biopsy for cancer diagnostics; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).
  3. Testing techniques, such as HIV Testing, HPV Testing, Hepatitis Testing or Drug Testing

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Customer Support

Talk to Sam

+44 208 068 8943

120 Reports
Company, Company Financials, Market Size
120 Statistics
Market Size, Demand, Finance
1100 Reports
Company Financials, Social Conditions, Demand
230 Statistics
Market Size, Environment, Social Conditions
22 Reports
Demand, Social Conditions, Company Financials
77 Statistics
Market Size, Demand, Finance
41 Reports
Company Financials, Demand, Company
85 Statistics
Market Size, Demand, Finance
47 Reports
Social Conditions, Company, Demographic
96 Statistics
Environment, Social Conditions, Demographic
16 Reports
Market Size, Social Conditions, Supply
52 Statistics
Market Size, Finance, Company Financials
28 Reports
Demographic, Social Conditions, Company Financials
32 Statistics
Demographic, Environment, Social Conditions
13 Reports
Social Conditions, Demographic, Company Financials
50 Statistics
Social Conditions, Environment, Demographic
17 Reports
Company, Company Financials, Market Size
48 Statistics
Finance, Company Financials, Market Size
4 Reports
Social Conditions, Supply, Demographic
28 Statistics
Social Conditions, Environment, Demographic

About 12000 reports

Purchase Reports From Reputable Market Research Publishers

Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest  Technologies and Instrumentation

Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

  • $ 35000
  • Industry report
  • September 2019

Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies ...

World Cancer Diagnostics Market: Emerging Opportunities ... $ 35000 August 2019

World Hemostasis Diagnostic Analyzers and Reagent Marke ... $ 33500 September 2019

World Coagulation Testing Analyzers and Reagents Market ... $ 28500 August 2019

Competing in the Global Coagulation Testing Market, 201 ... $ 21100 July 2019

Hemostasis Analyzers and Reagents Market, 2019-2023: Su ... $ 21100 July 2019

Competing in the Global Molecular Diagnostics Market, 2 ... $ 20900 July 2019

Global Hemostasis Diagnostic Analyzers and Reagent Mark ... $ 19500 September 2019

Europe Cancer Diagnostics Market: A 31-Country Analysis ... $ 19500 August 2019

Competing in the Global Clinical Chemistry and Immunodi ... $ 19500 July 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on